重组乙肝病毒核心抗原
英文名称 | Recombinant HBcAg protein, Tag free |
中文名称 | 重组乙肝病毒核心抗原 |
别 名 | C; Capsid protein; Core and e antigen; Core antigen; Core antigen; Core protein; HBc; HBVgp4; Hepatitis B Virus core antigen; p21.5; Hepatitis B Virus Core Antigen; precore/core protein; CAPSD_HBVA3. |
理论分子量 | 20kDa |
检测分子量 | 23 kDa |
性 状 | Lyophilized or Liquid |
浓 度 | >0.5mg/ml |
物 种 | HBV |
序 列 | 1-185/185 |
纯 度 | > 95% as determined by SDS- PAGE |
纯化方法 | AC |
内毒素 | Not analyzed |
表达系统 | E.coli |
活性 | Not tested |
标签 | Tag free |
缓 冲 液 | Lyophilized from sterile 50mM Na2SO4, 0.5mM DTT, 1mM EDTA, 20mM Tris (pH=7.5) |
保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
产品介绍 | Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner "core particle" enclosing the viral genome. The icosahedral core particle contains 180 or 240 copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection. The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection. |